What Does a Short PR Interval Mean?

A short PR interval on an electrocardiogram (ECG) means electrical signals are traveling from your heart’s upper chambers to its lower chambers faster than usual, typically in less than 120 milliseconds. In many people this is a harmless finding with no symptoms and no consequences. In others, it signals an accessory electrical pathway in the heart that can set the stage for abnormal heart rhythms. The difference between “nothing to worry about” and “needs further evaluation” depends on whether other ECG changes accompany the short interval, whether you have symptoms, and sometimes on your age and activity level.

Why the PR Interval Exists

Every heartbeat starts with an electrical impulse in the upper chambers (atria). That impulse has to reach the lower chambers (ventricles) to trigger them to pump blood. Between the two sits the atrioventricular (AV) node, a small cluster of cells that deliberately slows the signal down. This built-in delay is the PR interval you see on an ECG. The AV node’s slowing serves a purpose: it gives the ventricles time to fill with blood before they contract.¹ A normal PR interval runs roughly 120 to 200 milliseconds. When it drops below 120 ms, the signal is arriving at the ventricles sooner than expected.

There are really only two broad reasons this happens. Either the AV node itself conducts faster than average (which can be perfectly normal, especially in younger or more athletic hearts), or the electrical impulse is bypassing part or all of the AV node through an extra pathway that shouldn’t be there. The clinical significance hinges almost entirely on which of those explanations applies.

The Harmless Short PR Interval

Many short PR intervals show up on routine ECGs in people who feel perfectly fine. This is especially common in children, adolescents, and trained athletes. A cross-sectional study of over 1,300 young athletes found that about 27% had a PR interval under 120 ms using the standard cutoff. When the researchers adjusted for age and sex using a more statistically refined threshold, the proportion dropped to under 4%. Crucially, neither group showed any meaningful link between the short PR interval and cardiac symptoms like syncope, palpitations, chest pain, or exercise-triggered arrhythmias.²

International recommendations for interpreting athletes’ ECGs recognize this. A short PR interval in an asymptomatic athlete does not automatically require further investigation unless there are signs of an accessory pathway.³ In practice, though, athletes are still frequently referred for additional testing, which can lead to unnecessary anxiety and cost. The finding, on its own, is not a diagnosis of anything. It is a measurement that sometimes points to something and sometimes doesn’t.

Enhanced vagal tone, the heightened activity of the nerve that naturally slows heart rate, is one reason athletes tend to have different-looking ECGs than sedentary people. Their hearts are conditioned in ways that shift several ECG measurements, and a slightly faster conduction through the AV node is one possible result. The same applies to many young people whose nervous systems simply allow faster conduction as a normal variant.

When a Short PR Interval Means Pre-Excitation

The scenario that concerns doctors is pre-excitation, which means the ventricles are being activated earlier than they should be because the electrical signal is taking a shortcut. The most well-known version is Wolff-Parkinson-White (WPW) syndrome. In WPW, an extra band of muscle tissue creates a direct electrical bridge between the atria and ventricles, bypassing the AV node entirely. Because the signal doesn’t get slowed down, it arrives at the ventricles early, producing a short PR interval on the ECG.⁴

WPW has three hallmark features on an ECG: a short PR interval (under 120 ms), a widened QRS complex (the wave representing ventricular contraction), and a distinctive slurred upstroke at the beginning of the QRS called a delta wave.⁵ That delta wave is the giveaway. It reflects the ventricle beginning to activate through the accessory pathway before the normal conduction system has caught up. If your ECG shows a short PR interval without a delta wave and without a widened QRS, WPW is far less likely.

WPW matters because the accessory pathway can participate in a re-entrant circuit. Electrical signals loop continuously between the normal pathway and the bypass tract, causing the heart to race. These episodes can manifest as sudden palpitations, dizziness, or fainting. In rare but dangerous cases, if the person develops atrial fibrillation, the accessory pathway can conduct the chaotic atrial signals to the ventricles at extremely high rates, potentially triggering ventricular fibrillation.⁶ This is the reason WPW gets taken seriously even in people who haven’t had symptoms yet.

Lown-Ganong-Levine Syndrome and Enhanced AV Node Conduction

There is another, more controversial pattern historically called Lown-Ganong-Levine (LGL) syndrome. In LGL, the ECG shows a short PR interval and a normal QRS complex with no delta wave, but the person experiences episodes of rapid heart rhythm. The original explanation was that a tiny bypass fiber (called a James fiber) connects the atrium to the lower part of the AV node, skipping the slow part of normal conduction. A case report in the American Journal of Case Reports documented exactly this: a patient with a short PR interval, normal QRS, no delta wave, and recurrent episodes of fast heart rhythm. Electrophysiology testing revealed an accessory connection from the atrium to the distal AV node with unusual conduction properties that normalized after catheter ablation.⁷

The debate around LGL is whether these cases really involve a discrete bypass tract or simply represent enhanced conduction through a normal AV node. Many electrophysiologists today consider LGL syndrome poorly defined and use the broader term “enhanced AV nodal conduction” instead. In practical terms, the distinction matters less than the clinical picture: if you have a short PR interval, a normal QRS, and no symptoms, the finding alone is not treated. If you also have recurrent episodes of rapid heart rhythm, your doctor may recommend electrophysiology testing regardless of what the pattern is called.

A Genetic Link Worth Knowing About

One lesser-known cause of a short PR interval is a genetic condition called PRKAG2 syndrome. This results from mutations in a gene that regulates energy metabolism in heart muscle cells. The mutations cause abnormal storage of a sugar-like substance (glycogen) in the heart tissue, which can disrupt the normal conduction system. A study of the clinical spectrum of PRKAG2 syndrome found that a short PR interval was the most common electrocardiographic feature, present in about two-thirds of affected patients.⁸

PRKAG2 syndrome is rare, but it is worth mentioning because it can mimic WPW on an ECG while actually involving a completely different mechanism. Rather than a muscular bypass tract, the glycogen deposits create electrical shortcuts through the normally insulating tissue between atria and ventricles. The condition can also cause thickening of the heart walls, which can initially be misdiagnosed as a more common form of cardiomyopathy. If a short PR interval appears alongside unexplained heart-wall thickening, especially in a younger patient with a family history of similar findings, genetic testing for PRKAG2 mutations may be warranted.

How Doctors Decide Whether to Investigate Further

The decision tree for a short PR interval is more about context than the measurement itself. A short PR in isolation, with no delta wave, no widened QRS, and no symptoms, rarely leads anywhere concerning. When additional ECG abnormalities or symptoms are present, the workup typically begins with ambulatory heart monitoring (wearing a portable monitor for a day or longer) and may progress to an electrophysiology study, which involves threading thin wires into the heart through a vein to map its electrical activity in detail.

For people with the WPW ECG pattern but no symptoms, the question of whether to perform an electrophysiology study is genuinely debated. One large prospective study of asymptomatic WPW patients found that electrophysiology testing could meaningfully predict who would later develop symptomatic arrhythmias. Those with inducible sustained re-entrant tachycardia and atrial fibrillation during testing were far more likely to become symptomatic, and they tended to be younger and to have shorter accessory pathway refractory periods and multiple pathways.⁹ In children and adolescents with the WPW pattern, roughly a third showed adverse accessory pathway properties at baseline during electrophysiology testing, with additional cases emerging after drug provocation.¹⁰

Current guidelines from the American College of Cardiology and American Heart Association emphasize systematic risk assessment. They advise clinicians to weigh the presence of symptoms (syncope, palpitations), the electrical properties of the accessory pathway (how fast it can conduct and recover), and any coexisting structural heart disease.⁶ A young person with a WPW pattern who plays competitive sports, for example, may be referred for risk stratification even without symptoms, because the stakes of a rare but possible lethal arrhythmia during intense exertion justify the investigation.

Treatment When the Pathway Poses a Risk

When a problematic accessory pathway is confirmed, catheter ablation is the definitive treatment. This procedure uses a thin catheter threaded to the heart to deliver targeted energy (usually radiofrequency heat) to the small area where the accessory pathway connects, permanently destroying it. A large registry study of over 2,100 WPW patients found that ablation was successful in about 98.5% of cases. Over an eight-year follow-up, none of the patients who underwent successful ablation developed malignant arrhythmias or ventricular fibrillation. In contrast, untreated patients were significantly more likely to experience dangerous arrhythmias over the same period.¹¹

These numbers make catheter ablation one of the more clear-cut success stories in cardiac procedures. It is generally considered low-risk, though complications like damage to normal conduction tissue, bleeding, or vascular injury can occasionally occur. For people with symptomatic WPW, ablation is first-line therapy. For asymptomatic patients with high-risk features on electrophysiology testing, ablation performed during the same session as the diagnostic study has become increasingly common, sparing the patient a second procedure.

Medications can also manage symptoms in some cases, particularly when ablation isn’t feasible or the patient prefers a less invasive approach. Certain antiarrhythmic drugs slow conduction through the accessory pathway or the AV node, reducing the frequency and severity of arrhythmic episodes. However, some common drugs used for other types of rapid heart rhythms can be dangerous in WPW because they slow conduction through the AV node without affecting the bypass tract, potentially funneling all electrical traffic through the accessory pathway and worsening the situation. Drug choice in pre-excitation needs to be deliberate.

Short PR Interval and the Risk of Syncope

An interesting and less widely known finding is the association between short PR intervals and outcomes in people who present with fainting episodes. A study in the Journal of the American Heart Association examined patients who came to medical attention because of syncope and found that those with a short PR interval had a meaningfully higher risk of recurrent fainting compared to those with normal or prolonged PR intervals. After adjusting for age, sex, and other factors, the short PR group had roughly a 50% higher hazard for recurrence. The same group also had a higher five-year cumulative mortality rate of about 18%, compared to 14% in those with a normal PR interval and 13% in those with a long PR interval.¹²

This does not mean a short PR interval causes death. The association likely reflects underlying differences in cardiac conduction or autonomic nervous system function that also predispose people to fainting and its complications. But it does suggest that a short PR interval in a patient who has already fainted is not a finding to dismiss. It could flag someone who warrants closer monitoring or a more thorough cardiac workup, even if the short PR alone wouldn’t have prompted concern.

The Intermittent Problem

One complication that can trip up diagnosis is that pre-excitation is not always visible. In some people with WPW, the accessory pathway conducts intermittently, meaning the classic ECG changes come and go. An ECG taken on a day when the pathway isn’t conducting will look completely normal. This is why a single normal ECG doesn’t necessarily rule out an accessory pathway in someone with suspicious symptoms. Ambulatory monitoring over a longer period, or exercise stress testing that raises the heart rate and may provoke the pathway into conducting, can sometimes unmask what a resting ECG misses.⁵

Paradoxically, intermittent pre-excitation has sometimes been considered a reassuring sign, suggesting the pathway may have a longer refractory period and therefore be less capable of conducting dangerously rapid rhythms. But this is an oversimplification. The pathway’s behavior during an electrophysiology study under controlled conditions gives a much more reliable picture of risk than whether it happens to show up on a resting ECG.

How the Understanding of Pre-Excitation Evolved

The story of WPW syndrome stretches back over a century and involves a fascinating case of mistaken anatomy. In the early 1900s, an anatomist named Stanley Kent described muscular connections bridging the atria and ventricles, which he believed were part of the heart’s normal wiring. He was wrong about them being normal, but right that they existed. The actual normal conduction pathway through the His bundle and its branches had already been described by other anatomists. It wasn’t until 1930 that Wolff, Parkinson, and White published the landmark paper pulling together the clinical features of what we now call WPW syndrome, though earlier case reports had described essentially the same thing. The concept that the syndrome involved a re-entrant circuit using both the normal conduction system and the accessory pathway was later articulated by David Scherf.¹³

That historical arc matters because it illustrates how long it took to move from observing a pattern on paper tracings to understanding the mechanism well enough to treat it. The development of catheter ablation in the late twentieth century transformed WPW from a lifelong condition managed with medications and surgical risk into something that can be cured in a single procedure. For people whose short PR interval turns out to reflect one of these accessory pathways, the prognosis today is radically better than it was even a few decades ago.